PITTSBURGH, July 8, 2021 /PRNewswire/ -- Viatris Inc.
(NASDAQ: VTRS) plans to release its second quarter 2021 financial
results on Monday, Aug. 9, before the
open of the U.S. financial markets. Chief Executive
Officer Michael Goettler, President Rajiv Malik, and
Chief Financial Officer Sanjeev Narula also will host a
webcast at 10 a.m. ET on Aug. 9 to discuss the results.
Investors and the general public are invited to listen to a live
webcast of the call at investor.viatris.com or by calling
855.493.3607 or 346.354.0950 for international callers (ID#:
9972248). A replay of the webcast also will be available on
the website.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare
company, empowering people worldwide to live healthier at every
stage of life. We provide access to medicines, advance
sustainable operations, develop
innovative solutions and leverage our
collective expertise to connect more people to more
products and services through our one-of-a-kind Global
Healthcare Gateway®. Formed in November 2020, Viatris brings together
scientific, manufacturing and distribution expertise with proven
regulatory, medical and commercial capabilities to deliver
high-quality medicines to patients in more than 165 countries and
territories. Viatris' portfolio comprises more than 1,400 approved
molecules across a wide range of therapeutic areas, spanning both
non-communicable and infectious diseases, including globally
recognized brands, complex generic and branded medicines, a growing
portfolio of biosimilars and a variety of over-the-counter consumer
products. With a global workforce of approximately
45,000, Viatris is headquartered in the U.S., with
global centers in Pittsburgh,
Shanghai and Hyderabad, India. Learn more at
viatris.com and investor.viatris.com, and connect with us on
Twitter at @ViatrisInc, LinkedIn and YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-inc-to-release-second-quarter-2021-financial-results-on-aug-9-2021-301328210.html
SOURCE Viatris Inc.